Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 36, 2012, Pages 14610-14615

  Schoggins, John W ^a   Dorner, Marcus ^a   Feulner, Michael ^a   Imanaka, Naoko ^a   Murphy, Mary Y ^a   Ploss, Alexander ^a   Rice, Charles M ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Antiviral screening; Flavivirus; In vivo imaging; Interferon stimulated gene

Indexed keywords

ANTIVIRUS AGENT; FIREFLY LUCIFERASE; GAMMA INTERFERON; GREEN FLUORESCENT PROTEIN; INTERFERON; INTERFERON EFFECTOR; INTERFERON RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; BIOLUMINESCENCE; CELLULAR IMMUNODEFICIENCY; CONTROLLED STUDY; DENGUE; DENGUE REPORTER VIRUS; DENGUE VIRUS; EXPRESSION VECTOR; GENE EXPRESSION; GENE LIBRARY; GENETIC ENGINEERING; GENETIC SCREENING; IN VITRO STUDY; INTESTINE LYMPHATIC TISSUE; LIFE CYCLE; LYMPHOID TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; TISSUE DISTRIBUTION;

ANALYSIS OF VARIANCE; ANIMALS; CERCOPITHECUS AETHIOPS; DENGUE; DENGUE VIRUS; FLOW CYTOMETRY; GENE LIBRARY; GENES, REPORTER; GENETIC ENGINEERING; GREEN FLUORESCENT PROTEINS; HIGH-THROUGHPUT SCREENING ASSAYS; LUCIFERASES, FIREFLY; MICE; PLASMIDS; VERO CELLS;

DENGUE VIRUS; FLAVIVIRUS; MUS;

EID: 84866002833     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1212379109     Document Type: Article

References (38)

1. Guzman MG, et al. (2010) Dengue: A continuing global threat. Nat Rev Microbiol 8 (12):Suppl):S7-S16.
2. Centers for Disease Control and Prevention (CDC) (2010) Locally acquired Dengue - Key West, Florida, 2009-2010. MMWR Morb Mortal Wkly Rep 59:577-581.
3. Noble CG, et al. (2010) Strategies for development of Dengue virus inhibitors. Antiviral Res 85:450-462.
4. Puri B, Polo S, Hayes CG, Falgout B (2000) Construction of a full length infectious clone for dengue-1 virus Western Pacifi c,74 strain. Virus Genes 20:57-63. (Pubitemid 30168918)
5. Kinney RM, et al. (1997) Construction of infectious cDNA clones for dengue 2 virus: Strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology 230: 300-308. (Pubitemid 27211861)
6. Lai CJ, Zhao BT, Hori H, Bray M (1991) Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus. Proc Natl Acad Sci USA 88:5139-5143. (Pubitemid 21914699)
7. Rice CM, Grakoui A, Galler R, Chambers TJ (1989) Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation. New Biol 1: 285-296.
8. Iglesias NG, Gamarnik AV (2011) Dynamic RNA structures in the dengue virus genome. RNA Biol 8:249-257.
9. Alvarez DE, Lodeiro MF, Ludueña SJ, Pietrasanta LI, Gamarnik AV (2005) Long-range RNA-RNA interactions circularize the dengue virus genome. J Virol 79:6631-6643. (Pubitemid 40677294)
10. Friebe P, Harris E (2010) Interplay of RNA elements in the dengue virus 5′ and 3′ ends required for viral RNA replication. J Virol 84:6103-6118.
11. Zou G, Xu HY, Qing M, Wang QY, Shi PY (2011) Development and characterization of a stable luciferase dengue virus for high-throughput screening. Antiviral Res 91: 11-19.
12. Kaptein SJ, et al. (2010) A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro. Antimicrob Agents Chemother 54:5269-5280.
13. Samsa MM, et al. (2009) Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS Pathog 5:e1000632.
14. Luker KE, Luker GD (2008) Applications of bioluminescence imaging to antiviral research and therapy: Multiple luciferase enzymes and quantitation. Antiviral Res 78: 179-187.
15. Pósfai G, et al. (2006) Emergent properties of reduced-genome Escherichia coli. Science 312:1044-1046.
16. Agapov EV, et al. (1998) Noncytopathic Sindbis virus RNA vectors for heterologous gene expression. Proc Natl Acad Sci USA 95:12989-12994. (Pubitemid 28509511)
17. McGee CE, et al. (2010) Infection, dissemination, and transmission of a West Nile virus green fluorescent protein infectious clone by Culex pipiens quinquefasciatus mosquitoes. Vector Borne Zoonotic Dis 10:267-274.
18. Tsetsarkin K, et al. (2006) Infectious clones of Chikungunya virus (La Réunion isolate) for vector competence studies. Vector Borne Zoonotic Dis 6:325-337.
19. Manicassamy B, et al. (2010) Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc Natl Acad Sci USA 107:11531-11536.
20. Diamond MS, Zachariah M, Harris E (2002) Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA. Virology 304:211-221.
21. Yin Z, et al. (2009) An adenosine nucleoside inhibitor of dengue virus. Proc Natl Acad Sci USA 106:20435-20439.
22. Johnson AJ, Roehrig JT (1999) New mouse model for dengue virus vaccine testing. J Virol 73:783-786. (Pubitemid 28565427)
23. Williams KL, Zompi S, Beatty PR, Harris E (2009) A mouse model for studying dengue virus pathogenesis and immune response. Ann N Y Acad Sci 1171(Suppl 1):E12-E23.
24. Yauch LE, Shresta S (2008) Mouse models of dengue virus infection and disease. Antiviral Res 80:87-93.
25. Grant D, et al. (2011) A single amino acid in nonstructural protein NS4B confers virulence to dengue virus in AG129 mice through enhancement of viral RNA synthesis. J Virol 85:7775-7787.
26. Pham AM, Langlois RA, TenOever BR (2012) Replication in cells of hematopoietic origin is necessary for Dengue virus dissemination. PLoS Pathog 8:e1002465.
27. Kyle JL, Beatty PR, Harris E (2007) Dengue virus infects macrophages and dendritic cells in a mouse model of infection. J Infect Dis 195:1808-1817. (Pubitemid 46870254)
28. Balsitis SJ, et al. (2009) Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining. Am J Trop Med Hyg 80:416-424.
29. Diamond MS, et al. (2000) Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol 74:4957-4966. (Pubitemid 30313834)
30. Schoggins JW, et al. (2011) A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:481-485.
31. Brass AL, et al. (2009) The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139:1243-1254.
32. Dupuis S, et al. (2003) Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat Genet 33:388-391. (Pubitemid 36278855)
33. Feeley EM, et al. (2011) IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog 7:e1002337.
34. Zellweger RM, Prestwood TR, Shresta S (2010) Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host Microbe 7:128-139.
35. Ashour J, Laurent-Rolle M, Shi PY, García-Sastre A (2009) NS5 of dengue virus mediates STAT2 binding and degradation. J Virol 83:5408-5418.
36. Jones M, et al. (2005) Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. J Virol 79:5414-5420. (Pubitemid 40548209)
37. Reed LJ, Muench H (1938) A simple method of estimating fifty per cent endpoints. Am J Epidemiol 72:493-497.
38. Lambeth CR, White LJ, Johnston RE, de Silva AM (2005) Flow cytometry-based assay for titrating dengue virus. J Clin Microbiol 43:3267-3272. (Pubitemid 40981334)